Betsy Gelfand

Betsy Gelfand is a finance professional with extensive experience in the biotechnology sector. Currently serving as the Senior Vice President of Finance at Endeavor BioMedicines since November 2024, Betsy has held significant roles at Mirati Therapeutics from June 2020 to November 2024, including Chief Accounting Officer, VP of Finance, and Senior Director of Finance and Accounting. Prior to that, Betsy was the Senior Director of Finance and Accounting at Tocagen Inc. from May 2018 to June 2020 and served as Controller and Associate Director of Accounting & Financial Reporting at Regulus Therapeutics from May 2014 to May 2018. Betsy began their career as an Audit Senior Manager at Grant Thornton LLP, where Betsy worked from August 2006 to May 2014. Betsy holds a Bachelor's degree in Accounting from the University of San Diego, earned between 2002 and 2006.